Ludwigshafen/Germany, Leuven/Belgium – July 19, 2018 – BASF is expanding its cooperation with Materialise, a leading supplier of 3D printing technologies. At the same time, BASF has agreed to invest US$25 million in the Belgian company, which is headquartered in Leuven. The two partners are working together within the framework of an open business model to continuously improve materials and software for various 3D printing technologies and bring them more rapidly to the market. The companies are focusing on applications in the consumer goods sector and in the automotive and aviation industries. The agreement allows for systematic, wider scale testing and further optimization by BASF of its materials on the machines and within the infrastructure of Materialise.
Read more
Leuven, Belgium, July 19, 2018 – Materialise NV ("Materialise") (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, announced today that it intends to commence a registered underwritten public offering of 3.0 million ADSs. Each ADS will represent one ordinary share with no nominal value per share. Materialise intends to grant the underwriters a 30-day option to purchase up to an additional 450,000 ADSs. All of the ADSs in the proposed offering are to be sold by Materialise. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.
Read more
Lier, Belgium - 12 juli, 2018. Voor de allereerste keer zal een volledig mammoet-skelet op ware grootte in 3D geprint worden. Het gaat om een reproductie van de Mammoet van Lier, het eerste bijna volledige mammoet-skelet van België, dat in 1860 bij graafwerken in de Pallieterstad is gevonden. Het skelet werd ondergebracht in het Museum voor Natuurwetenschappen in Brussel, waar het nog altijd te zien is.
Read more
Leuven, Belgium – June 19, 2018. Materialise NV (NASDAQ: MTLS) is a world leader in the development of technology enabling personalized healthcare solutions. Materialise’s latest patent, accepted by the Australian Patent Office, concerns Materialise’s 3D planning technologies and 3D-printed guides which enable the design of screw placements for the fit and fixation of customized implants. With the recent expansion of its portfolio of medical patents, Materialise continues to strengthen its unique position in the healthcare industry, supporting its commitment to help patients worldwide through technological innovation.
Read more
Materialise has partnered with HCL Technologies to develop a platform that provides increased integration for hybrid manufacturing. With this collaboration, CAMWorksR software from HCL will be Powered by Materialise AM technology to facilitate the production of metal parts, combining the benefits of AM freedom of design with the speed and accuracy of CNC machining.
Read more
